These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2123559)

  • 1. Fluvoxamine in the treatment of menstrually related mood disorders.
    Veeninga AT; Westenberg HG; Weusten JT
    Psychopharmacology (Berl); 1990; 102(3):414-6. PubMed ID: 2123559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.
    Wood K; Swade C; Abou-Saleh M; Milln P; Coppen A
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):365S-368S. PubMed ID: 6407498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR; Sireling LI; Bhat AV; Rao B; Paykel ES
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo controlled double-blind trial of fluvoxamine maleate in the obese.
    Abell CA; Farquhar DL; Galloway SM; Steven F; Philip AE; Munro JF
    J Psychosom Res; 1986; 30(2):143-6. PubMed ID: 3088266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine.
    Coleman BS; Block BA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):475-8. PubMed ID: 6819596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder.
    Mullin JM; Pandita-Gunawardena VR; Whitehead AM
    Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice.
    Laws D; Ashford JJ; Anstee JA
    Acta Psychiatr Scand; 1990 Feb; 81(2):185-9. PubMed ID: 2109498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.
    Dick P; Ferrero E
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):419S-425S. PubMed ID: 6407502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
    Goodman WK; Price LH; Rasmussen SA; Delgado PL; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D; Bailly D; Le Seac'h H; Parquet PJ
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Belgian multicentre study of fluvoxamine in depressive outpatients.
    Brasseur R; Van Moffaert M; Mesotten F; Ansseau M; Uytdenhoef P; Bartholome F
    Acta Psychiatr Belg; 1985; 85(5):636-43. PubMed ID: 3937441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.